Jill C. Milne insider trades

Open-market stock purchases and sales by Jill C. Milne, Director at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Jun 30, 2015.

Recent trades

DateStockTradeValue
Aug 31, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)$12.5K
Jun 11, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Jun 11, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
May 29, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)$11.2K
Feb 27, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)$4.6K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)—
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.3M
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$4.9M
Jan 23, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Jan 23, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Jan 23, 2026BCRX Biocryst Pharmaceuticals IncBought (not open market)—

Companies traded

  • BCRX Biocryst Pharmaceuticals Inc: other filings, last Aug 31, 2026
  • ATXS Astria Therapeutics, Inc: other filings, last Jan 23, 2026
  • CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 2, 2021

Get free alerts when Jill C. Milne files a new trade →